Apyx Medical Corp. (NASDAQ: APYX) reported Q1 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $12.1 million versus the consensus estimate of $10.81 million.

GUIDANCE:

Apyx Medical Corp. sees FY2023 revenue of $59-62 million, versus the consensus of $58.053 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.